THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
批准号:
8293085
负责人:
Samuel Refetoff
金额:
$57.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-07-15 至 2016-06-30
关键词:
AffectAnimal ExperimentsAnimal ModelCase StudyCell membraneCellsClinicalClinical ResearchComplementDefectDevelopmentDiagnosisDiseaseEmbryoFetusFibroblastsFunctional disorderFundingGene ExpressionGene MutationGenesGenetic CounselingGenetic TranscriptionGenotypeHumanImmunohistochemistryIn VitroInborn Genetic DiseasesInheritedInstructionInvestigationKnowledgeLaboratoriesLettersLifeLinkMediatingMediationMetabolismModalityMothersMouse StrainsMusMutationNuclearOrganPatientsPhenotypePhysiologyPositioning AttributePostdoctoral FellowPostpartum PeriodPrenatal DiagnosisProcessPropertyResearchResearch ProposalsResistanceScreening procedureSeleniumSkinSupplementationSyndromeTestingTherapeutic EffectTherapeutic InterventionThyroid GlandThyroid Hormone ReceptorThyroid Hormone Receptor BetaThyroid HormonesTimeTissuesTranslationsTransmembrane TransportVariantWomanhormone metabolismin vivoinsightmaleoffspringprenatalprogramsselenocysteine insertion sequence binding protein 2selenoproteintranslational approach
中文摘要
这项研究计划的广泛目标是通过研究关键调控过程中的遗传缺陷来促进对甲状腺生理学的理解。除了识别新的综合征和基因缺陷外,研究中心还通过研究由于细胞膜运输、代谢和作用缺陷而导致的对TH敏感性降低的综合征来介导甲状腺激素(TH)的作用。这些分别由MCT8(单羧酸转运蛋白8)、SBP 2(硒代半胱氨酸插入序列结合蛋白2)和TRI1(核TH受体IJ)基因以及尚未鉴定的其他基因中的突变引起。每一种都通过三重方法进行研究,临床(体内),组织和基因表达(体外)和动物模型(基因改变小鼠,重现人类的缺陷)。每一种方法都是对另一种方法的补充,并弥补其固有的局限性。1.临床研究将有助于更好地表征表型,以确定TH转运和代谢中的组织和器官特异性缺陷。研究将包括产前基因分型和尝试治疗。将寻找新的变异和不寻常的表型。2.使用患者皮肤成纤维细胞的原代培养和缺陷基因的异源表达的体外研究将用于确定分离的缺陷分子的性质。在SBP2缺陷的情况下,体外研究将用于确定各种突变对基因转录和翻译的影响。通过免疫组织化学检查患者组织,将有助于在细胞水平上识别缺陷的后果,并验证动物实验产生的结果的相关性。3.缺乏所研究物质的小鼠和携带在人类中观察到的突变的小鼠将允许更好地表征所研究的缺陷,并测试各种可能的治疗方式。Mct8基因缺陷的小鼠已被证明在人类甲状腺异常的理解是非常宝贵的,现在将用于描述Mct8缺陷在胚胎和产后早期生活中的后果以及产前治疗干预的潜力。诱导型Sbp2K0小鼠的建立将有助于确定对生存和发育至关重要的硒蛋白表达的时间,以及它们缺乏的后果。将应用大规模平行测序来鉴定参与TH抗性的基因,该基因不与TRIi基因连锁。因此,这些新基因的功能将被表征。
英文摘要
The broad objective of this research proposal is to advance understanding of thyroid physiology through study of genetic defects at key regulatory processes. In addition to identification of new syndromes and gene defects, research centers on the mediation of thyroid hormone (TH) effects by studying syndromes of reduced sensitivity to TH due to defects in cell membrane transport, metabolism and action. These are caused, respectively, by mutations in the MCT8 (monocarboxylate transporter 8), SBP2 (selenocysteine insertion sequence-binding protein 2) and TRIl (nuclear TH receptor IJ) genes and others not yet identified. Each is studied by a triple approach, clinical (in vivo), tissue and gene expression (in-vitro) and animal models (gene altered mice that recapitulate the defect in humans). Each approach complements the other and compensates for their inherent limitations. 1. Clinical studies will serve to better characterize the phenotype, to identify tissue and organ specific defects in TH transport and metabolism. Studies will include prenatal genotyping and attempted treatment. New variants and unusual phenotypes will be sought. 2. In vitro studies using primary culture of the patients' skin fibroblasts and heterologous expression of the defective genes will serve to determine the properties of the defective molecules in isolation. In the case of SBP2 defects, in vitro studies will serve to determine the effects of various mutations on gene transcription and translation. Examination of patients' tissues by immunohistochemistry, will serve to identify the consequences of the defects at the cell level and to verify the pertinence of results generated from animal experiment. 3. Mice deficient in the substances being studied and those harboring the mutations observed in humans, will allow for better characterization of the defects under investigation and for the testing of various modalities of potential treatment. Mice deficient in the Mct8 gene have proven invaluable in the understanding of the thyroid abnormalities in humans and will now serve to characterize the consequences of Mct8 deficiency in embryonic and early postpartum life and the potentials of prenatal therapeutic intervention. The creation of inducible Sbp2K0 mice will facilitate determination of the timing of expression of selenoproteins that are crucial to survival and development, as well as the consequences of their deficiency. Massively-parallel sequencing will be applied for the identification of the gene(s) involved in resistance to TH not linked to the TRIi gene. Thus, function of such new genes will be characterized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
-
批准号:8049871
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2010
-
负责人:Samuel Refetoff
-
依托单位:
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
-
批准号:7920503
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2009
-
负责人:Samuel Refetoff
-
依托单位:
SCREENING FOR INHERITED THYROID DEFECTS
-
批准号:7604798
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:Samuel Refetoff
-
依托单位:
RESISTANCE TO THYROID HORMONE
-
批准号:7378604
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2006
-
负责人:Samuel Refetoff
-
依托单位:
Diabetes Research and Training Center
-
批准号:7500641
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2006
-
负责人:Samuel Refetoff
-
依托单位:
LIGAND ASSAY CORE
-
批准号:7660179
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2005
-
负责人:Samuel Refetoff
-
依托单位:
LIGAND ASSAY CORE
-
批准号:7660140
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2004
-
负责人:Samuel Refetoff
-
依托单位:
Screening for Inherited Thyroid Defects
-
批准号:7040732
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2004
-
负责人:Samuel Refetoff
-
依托单位:
Resistance and Hypersensitivity to Thyroid Hormone
-
批准号:7040687
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2004
-
负责人:Samuel Refetoff
-
依托单位:
RESISTANCE & HYPERSENSITIVITY TO THYROID HORMONE--EFFECTS OF TRIIODOTHYRONINE
-
批准号:6304541
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1999
-
负责人:Samuel Refetoff
-
依托单位:
SCREENING FOR INHERITED THYROID DEFECTS
-
批准号:6304544
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1999
-
负责人:Samuel Refetoff
-
依托单位:
SCREENING FOR INHERITED THYROID DEFECTS
-
批准号:6264114
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1998
-
负责人:Samuel Refetoff
-
依托单位:
RESISTANCE & HYPERSENSITIVITY TO THYROID HORMONE--EFFECTS OF TRIIODOTHYRONINE
-
批准号:6264111
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1998
-
负责人:Samuel Refetoff
-
依托单位:
3RD INTERNATL WORKSHOP ON RESISTANCE TO THYROID HORMONE
-
批准号:2383161
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:Samuel Refetoff
-
依托单位:
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
-
批准号:6177069
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
-
批准号:6769966
-
项目类别:
-
资助金额:$47.2万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
STUDIES ON REGULATION AND MECHANISM OF HORMONE ACTION
-
批准号:3225337
-
项目类别:
-
资助金额:$24.82万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
REGULATION AND MECHANISMS OF HORMONE ACTION
-
批准号:2136889
-
项目类别:
-
资助金额:$36.68万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
STUDIES ON REGULATION AND MECHANISM OF HORMONE ACTION
-
批准号:3225335
-
项目类别:
-
资助金额:$23.63万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
REGULATION AND MECHANISM OF HORMONE ACTION
-
批准号:3483079
-
项目类别:
-
资助金额:$30.19万
-
财政年份:1979
-
负责人:Samuel Refetoff
-
依托单位:
海外基金